{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:25:50Z","timestamp":1793139950278,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Jilin Provincial Department of Finance","doi-asserted-by":"crossref","award":["JLSWSRCZX2020-058"],"award-info":[{"award-number":["JLSWSRCZX2020-058"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007452","name":"WU JIEPING Medical Foundation","doi-asserted-by":"crossref","award":["320.6750.2020-06-37"],"award-info":[{"award-number":["320.6750.2020-06-37"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20210401154YY"],"award-info":[{"award-number":["20210401154YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74737-2","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:01:56Z","timestamp":1728540116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study"],"prefix":"10.1038","volume":"14","author":[{"given":"Hongliang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulipikaer","family":"Aihemaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"74737_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bju.15286","volume":"127","author":"BM Launer","year":"2021","unstructured":"Launer, B. M., McVary, K. T., Ricke, W. A. & Lloyd, G. L. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 127, 722\u2013728 (2021).","journal-title":"BJU Int."},{"key":"74737_CR2","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.biopha.2017.08.016","volume":"94","author":"FU Khan","year":"2017","unstructured":"Khan, F. U. et al. Comprehensive overview of prostatitis. Biomed. Pharmacother. 94, 1064\u20131076 (2017).","journal-title":"Biomed. Pharmacother"},{"issue":"Suppl 1","key":"74737_CR3","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.ijantimicag.2007.08.027","volume":"31","author":"AJ Schaeffer","year":"2008","unstructured":"Schaeffer, A. J. Epidemiology and evaluation of chronic pelvic pain syndrome in men. Int. J. Antimicrob. Agents 31(Suppl 1), S108\u2013S111 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"74737_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00003495-200969010-00005","volume":"69","author":"AB Murphy","year":"2009","unstructured":"Murphy, A. B., Macejko, A., Taylor, A. & Nadler, R. B. Chronic prostatitis: management strategies. Drugs 69, 71\u201384 (2009).","journal-title":"Drugs"},{"key":"74737_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00345-003-0335-2","volume":"21","author":"TL Jang","year":"2003","unstructured":"Jang, T. L. & Schaeffer, A. J. The role of cytokines in prostatitis. World J. Urol. 21, 95\u201399 (2003).","journal-title":"World J. Urol."},{"key":"74737_CR6","doi-asserted-by":"publisher","first-page":"155440","DOI":"10.1016\/j.cyto.2021.155440","volume":"141","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Immunological alterations in patients with chronic prostatitis\/chronic pelvic pain syndrome and experimental autoimmune prostatitis model: a systematic review and meta-analysis. Cytokine 141, 155440 (2021).","journal-title":"Cytokine"},{"key":"74737_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/iju.14644","volume":"28","author":"H Tsunemori","year":"2021","unstructured":"Tsunemori, H. & Sugimoto, M. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: a literature review. Int. J. Urol. 28, 1086\u20131092 (2021).","journal-title":"Int. J. Urol."},{"key":"74737_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11934-019-0917-1","volume":"20","author":"GL Lloyd","year":"2019","unstructured":"Lloyd, G. L., Marks, J. M. & Ricke, W. A. Benign prostatic hyperplasia and lower urinary tract symptoms: what is the role and significance of inflammation? Curr. Urol. Rep. 20, 54 (2019).","journal-title":"Curr. Urol. Rep."},{"key":"74737_CR9","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ije\/dyw088","volume":"45","author":"DI Swerdlow","year":"2016","unstructured":"Swerdlow, D. I. et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int. J. Epidemiol. 45, 1600\u20131616 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"74737_CR10","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P., Del Greco, M. F., Pattaro, C. & K\u00f6ttgen, A. Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27, 3253\u20133265 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"74737_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"74737_CR12","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao, J. H. et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat. Immunol. 24, 1540\u20131551 (2023).","journal-title":"Nat. Immunol."},{"key":"74737_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce, B. L., Ahsan, H. & Vanderweele, T. J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 40, 740\u2013752 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"74737_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"74737_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G. & Thompson, S. G. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543\u2013552 (2015).","journal-title":"Eur. J. Epidemiol."},{"key":"74737_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"74737_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"74737_CR18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig, F. P., Davey Smith, G. & Bowden, J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 46, 1985\u20131998 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"74737_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12920-024-01812-y","volume":"17","author":"C Shen","year":"2024","unstructured":"Shen, C. et al. Preliminary study of the effect of gut microbiota on the development of prostatitis. BMC Med. Genomics 17, 35 (2024).","journal-title":"BMC Med. Genomics"},{"key":"74737_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"key":"74737_CR21","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"G Kramer","year":"2007","unstructured":"Kramer, G., Mitteregger, D. & Marberger, M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 51, 1202\u20131216 (2007).","journal-title":"Eur. Urol."},{"key":"74737_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pros.10084","volume":"52","author":"G Kramer","year":"2002","unstructured":"Kramer, G. et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate. 52, 43\u201358 (2002).","journal-title":"Prostate"},{"key":"74737_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","volume":"83","author":"GE Steiner","year":"2003","unstructured":"Steiner, G. E. et al. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab. Invest. 83, 1131\u20131146 (2003).","journal-title":"Lab. Invest."},{"key":"74737_CR24","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/j.juro.2008.03.139","volume":"179","author":"MA Pontari","year":"2008","unstructured":"Pontari, M. A. & Ruggieri, M. R. Mechanisms in prostatitis\/chronic pelvic pain syndrome. J. Urol. 179, S61\u2013S67 (2008).","journal-title":"J. Urol."},{"key":"74737_CR25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/andr.12747","volume":"8","author":"Q Zhao","year":"2020","unstructured":"Zhao, Q. et al. Lycopene attenuates chronic prostatitis\/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-\u03baB, MAPKs, and Nrf2 signaling pathways in rats. Andrology 8, 747\u2013755 (2020).","journal-title":"Andrology"},{"key":"74737_CR26","doi-asserted-by":"publisher","first-page":"17570","DOI":"10.1002\/jcp.28380","volume":"234","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. New therapy with XLQ(\u00ae) to suppress chronic prostatitis through its anti-inflammatory and antioxidative activities. J. Cell. Physiol. 234, 17570\u201317577 (2019).","journal-title":"J. Cell. Physiol."},{"key":"74737_CR27","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1111\/jcmm.16599","volume":"25","author":"L Zang","year":"2021","unstructured":"Zang, L. et al. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-\u03baB and inflammasome. J. Cell. Mol. Med. 25, 5753\u20135768 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"74737_CR28","doi-asserted-by":"publisher","first-page":"104607","DOI":"10.1016\/j.ebiom.2023.104607","volume":"92","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. IL-17\u00a0C neutralization protects the kidney against acute injury and chronic injury. EBioMedicine 92, 104607 (2023).","journal-title":"EBioMedicine"},{"key":"74737_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/pros.10238","volume":"56","author":"GE Steiner","year":"2003","unstructured":"Steiner, G. E. et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56, 171\u2013182 (2003).","journal-title":"Prostate"},{"key":"74737_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/13685538.2017.1284778","volume":"20","author":"J Arivazhagan","year":"2017","unstructured":"Arivazhagan, J., Nandeesha, H., Dorairajan, L. N. & Sreenivasulu, K. Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia. Aging Male 20, 115\u2013118 (2017).","journal-title":"Aging Male"},{"key":"74737_CR31","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/pros.23058","volume":"75","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: comparison with benign prostatic hyperplasia. Prostate 75, 1844\u20131856 (2015).","journal-title":"Prostate"},{"key":"74737_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O\u2019Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683\u2013765 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"74737_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10875-022-01366-7","volume":"43","author":"D Aschenbrenner","year":"2023","unstructured":"Aschenbrenner, D. et al. Pathogenic Interleukin-10 receptor alpha variants in humans\u2014balancing natural selection and clinical implications. J. Clin. Immunol. 43, 495\u2013511 (2023).","journal-title":"J. Clin. Immunol."},{"key":"74737_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0022-5347(01)69139-0","volume":"167","author":"LJ Miller","year":"2002","unstructured":"Miller, L. J. et al. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J. Urol. 167, 753\u2013756 (2002).","journal-title":"J. Urol."},{"key":"74737_CR35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.urology.2009.09.061","volume":"75","author":"L He","year":"2010","unstructured":"He, L., Wang, Y., Long, Z. & Jiang, C. Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis. Urology 75, 654\u2013657 (2010).","journal-title":"Urology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74737-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T10:01:57Z","timestamp":1728813717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74737-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74737"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74737-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study used publicly available de-identified data from participant studies that an ethical standards committee approved concerning human experimentation. Ethical approval was not necessary for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"23667"}}